BIOMAT Database Logo BIOMAT Database Logo

An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate. 2015

Dacie R Bridge, and Jeannette M Whitmire, and Jeremy J Gilbreath, and Eleanor S Metcalf, and D Scott Merrell
Department of Microbiology and Immunology, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA. Electronic address: dacie.bridge.ctr@usuhs.edu.

Due to increasing rates of invasive Salmonella enterica serovar Typhimurium infection, there is a need for an effective vaccine to prevent this disease. Previous studies showed that a mutation in the first gene of the Enterobacterial common antigen biosynthetic pathway, wecA, resulted in attenuation of S. Typhimurium in a murine model of salmonellosis. Furthermore, immunization with a wecA(-) strain protected against lethal challenge with the parental wild type S. Typhimurium strain. Herein, we examined whether the S. Typhimurium wecA(-) strain could also provide cross-protection against non-parental strains of S. Typhimurium and S. Enteritidis. We found that intraperitoneal immunization (IP) with S. Typhimurium SL1344 wecA(-) resulted in a significant increase in survival compared to control mice for all Salmonella challenge strains tested. Oral immunization with SL1344 wecA(-) also resulted in increased survival; however, protection was less significant than with intraperitoneal immunization. The increase in survival of SL1344 wecA(-) immunized mice was associated with a Salmonella-specific IgG antibody response. Furthermore, analysis of sera from IP and orally immunized animals revealed cross-reactive antibodies to numerous Salmonella isolates. Functional analysis of antibodies found within the sera from IP immunized animals revealed agglutination and opsonophagocytic activity against all tested O:4 Salmonella serovars. Together these results indicate that immunization with a S. Typhimurium wecA(-) strain confers protection against lethal challenge with wild type S. Typhimurium and S. Enteritidis and that immunization correlates with functional antibody production.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial

Related Publications

Dacie R Bridge, and Jeannette M Whitmire, and Jeremy J Gilbreath, and Eleanor S Metcalf, and D Scott Merrell
Enterobacterial common antigen mutants of Salmonella enterica serovar Typhimurium establish a persistent infection and provide protection against subsequent lethal challenge.
January 2012, Infection and immunity,
Dacie R Bridge, and Jeannette M Whitmire, and Jeremy J Gilbreath, and Eleanor S Metcalf, and D Scott Merrell
Evaluation of Salmonella enterica serovar Typhimurium TTSS-2 deficient fur mutant as safe live-attenuated vaccine candidate for immunocompromised mice.
January 2012, PloS one,
Dacie R Bridge, and Jeannette M Whitmire, and Jeremy J Gilbreath, and Eleanor S Metcalf, and D Scott Merrell
Proteome analysis of Salmonella enterica serovar Typhimurium fis mutant.
September 2003, FEMS microbiology letters,
Dacie R Bridge, and Jeannette M Whitmire, and Jeremy J Gilbreath, and Eleanor S Metcalf, and D Scott Merrell
Identification of an outer membrane protein of Salmonella enterica serovar Typhimurium as a potential vaccine candidate for Salmonellosis in mice.
May 2013, Microbes and infection,
Dacie R Bridge, and Jeannette M Whitmire, and Jeremy J Gilbreath, and Eleanor S Metcalf, and D Scott Merrell
Down-regulation of key virulence factors makes the Salmonella enterica serovar Typhimurium rfaH mutant a promising live-attenuated vaccine candidate.
October 2006, Infection and immunity,
Dacie R Bridge, and Jeannette M Whitmire, and Jeremy J Gilbreath, and Eleanor S Metcalf, and D Scott Merrell
Enterobacterial common antigen in mutant strains of Salmonella.
August 1978, Journal of bacteriology,
Dacie R Bridge, and Jeannette M Whitmire, and Jeremy J Gilbreath, and Eleanor S Metcalf, and D Scott Merrell
Characterization of a highly attenuated Salmonella enterica serovar Typhimurium mutant strain.
December 2002, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi,
Dacie R Bridge, and Jeannette M Whitmire, and Jeremy J Gilbreath, and Eleanor S Metcalf, and D Scott Merrell
Recombinant Salmonella enterica serovar Typhimurium as a vaccine vector for HIV-1 Gag.
August 2013, Viruses,
Dacie R Bridge, and Jeannette M Whitmire, and Jeremy J Gilbreath, and Eleanor S Metcalf, and D Scott Merrell
Evaluation of aroA deletion mutant of Salmonella enterica subspecies enterica serovar Abortusequi for its vaccine candidate potential.
November 2009, Indian journal of experimental biology,
Dacie R Bridge, and Jeannette M Whitmire, and Jeremy J Gilbreath, and Eleanor S Metcalf, and D Scott Merrell
Evaluation of the Salmonella enterica Serovar Pullorum Pathogenicity Island 2 Mutant as a Candidate Live Attenuated Oral Vaccine.
July 2015, Clinical and vaccine immunology : CVI,
Copied contents to your clipboard!